Search Results - "Siddals, Kirk W"
-
1
The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome
Published in Diabetes care (01-11-2004)“…The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome Kalpana Kaushal , MD 1 , Adrian H. Heald , DM 1 , Kirk W. Siddals , PHD 1…”
Get full text
Journal Article -
2
Apposite Insulin-like Growth Factor (IGF) Receptor Glycosylation Is Critical to the Maintenance of Vascular Smooth Muscle Phenotype in the Presence of Factors Promoting Osteogenic Differentiation and Mineralization
Published in The Journal of biological chemistry (13-05-2011)“…Vascular calcification is strongly linked with increased morbidity and mortality from cardiovascular disease. Vascular calcification is an active cell-mediated…”
Get full text
Journal Article -
3
Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways
Published in The Journal of biological chemistry (10-09-2004)“…The vasculoprotective effects of hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors (statins) correlate with cholesterol lowering. HMG-CoA reductase…”
Get full text
Journal Article -
4
Reduced Pericellular Sensitivity to IGF-I in Fibroblasts From Girls With Turner Syndrome: A Mechanism to Impair Clinical Responses to GH
Published in Pediatric research (01-07-2011)“…Girls with Turner syndrome (TS) are treated with supraphysiological doses of growth hormone (GH) to improve final height; however in some girls, the growth…”
Get full text
Journal Article -
5
Insulin-like growth factor-II and insulin-like growth factor binding protein-2 prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetes
Published in Annals of clinical biochemistry (01-07-2014)“…Associations of insulin-like growth factor-II (IGF-II) and insulin-like growth factor binding protein-2 (IGFBP-2) with cardiovascular risk have been…”
Get more information
Journal Article -
6
Atorvastatin administration is associated with dose-related changes in IGF bioavailability
Published in European journal of endocrinology (01-04-2013)“…ObjectiveIGF levels, their binding proteins (IGFBPs) and high-dose statin therapy have been linked to the development of diabetes. We aimed to identify whether…”
Get full text
Journal Article -
7
IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes
Published in Endocrine Connections (01-11-2012)“…ObjectiveInsulin-like growth factors are implicated in the development of diabetic nephropathy. IGF-binding protein 2 (IGFBP2) and IGF2 are expressed in the…”
Get full text
Journal Article -
8
Abrogation of Insulin-like Growth Factor-I (IGF-I) and Insulin Action by Mevalonic Acid Depletion
Published in The Journal of biological chemistry (10-09-2004)“…The vasculoprotective effects of hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors (statins) correlate with cholesterol lowering. HMG-CoA reductase…”
Get full text
Journal Article -
9
The effect of atorvastatin on serum lipoproteins in acromegaly
Published in Clinical endocrinology (Oxford) (01-06-2005)“…Objective Acromegaly is associated with long‐term adverse effects on cardiovascular mortality and morbidity. Reducing growth hormone secretion improves…”
Get full text
Journal Article -
10
IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes
Published in Endocrine Connections (25-02-2013)Get full text
Journal Article